Neuromuscular Ultrasound for Focal Neuropathies

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Michael S. Cartwright, Wake Forest School of Medicine

ClinicalTrials.gov Identifier:

NCT01394822

First received: July 13, 2011

Last updated: December 8, 2014

Last verified: December 2014

History of Changes

Purpose

The purpose of this study is to determine if a new diagnostic technique, called neuromuscular ultrasound, can improve our ability to diagnose focal nerve disease.

Condition
Focal Neuropathies Carpal Tunnel Syndrome Cubital Tunnel Syndrome Median Neuropathy Ulnar Neuropathy Peroneal Neuropathy Radial Neuropathy Sciatic Neuropathy Tibial Neuropathy


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Neuromuscular Ultrasound for Focal Neuropathies

Resource links provided by NLM:

Genetics Home Reference related topics: Charcot-Marie-Tooth disease hereditary neuropathy with liability to pressure palsies

MedlinePlus related topics: Carpal Tunnel Syndrome Ultrasound

Genetic and Rare Diseases Information Center resources: Charcot-Marie-Tooth Disease Hereditary Neuropathy With Liability to Pressure Palsy Roussy Levy Syndrome

U.S. FDA Resources

Further study details as provided by Wake Forest School of Medicine:

Primary Outcome Measures:

Overall Neuropathy Sum Score [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Neuropathy specific scale


Enrollment:	120
Study Start Date:	September 2011
Study Completion Date:	March 2014
Primary Completion Date:	March 2014 (Final data collection date for primary outcome measure)

Groups/Cohorts
Ultrasound results reported
Ultrasound results NOT reported

Eligibility


Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Individuals presenting to the Diagnostic Neurology Laboratory at Wake Forest Baptist Medical Center for evaluation of focal nerve disease.

Criteria

Inclusion Criteria:

Electrodiagnostic finding of focal nerve disease
Age 18 and older

Exclusion Criteria:

Skin lesions preventing ultrasound
Known ultrasound gel allergy
Unable to complete 6 months of follow-up

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01394822

Locations


United States, North Carolina
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157

Sponsors and Collaborators

Wake Forest School of Medicine

More Information

No publications provided


Responsible Party:	Michael S. Cartwright, Associate Professor, Wake Forest School of Medicine
ClinicalTrials.gov Identifier:	NCT01394822 History of Changes
Other Study ID Numbers:	NINDS-K23NS062892
Study First Received:	July 13, 2011
Last Updated:	December 8, 2014
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:


Nerve Compression Syndromes Ulnar Nerve Compression Syndromes Carpal Tunnel Syndrome Cubital Tunnel Syndrome Median Neuropathy Peroneal Neuropathies Radial Neuropathy Sciatic Neuropathy Syndrome Tibial Neuropathy	Cumulative Trauma Disorders Disease Mononeuropathies Nervous System Diseases Neuromuscular Diseases Pathologic Processes Peripheral Nervous System Diseases Sprains and Strains Ulnar Neuropathies Wounds and Injuries

ClinicalTrials.gov processed this record on February 27, 2015

To Top